{"id":169988,"date":"2025-08-11T03:23:17","date_gmt":"2025-08-11T07:23:17","guid":{"rendered":"https:\/\/44.250.171.167\/?p=169988"},"modified":"2025-08-11T03:23:17","modified_gmt":"2025-08-11T07:23:17","slug":"zydus-wellness-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/zydus-wellness-q1-fy26-earnings-results\/","title":{"rendered":"Zydus Wellness Q1 FY26 Earnings Results"},"content":{"rendered":"<p>Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite. Presenting below are its Q1 FY26 earnings results.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"q1-fy26-earnings-summary-apriljune-2025\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Q1 FY26 Earnings Results<\/h2>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Consolidated Revenue:<\/strong>\u00a0\u20b9861 crore, up 2.4% year-over-year (YoY) from \u20b9841 crore in Q1 FY25. Revenue is down 5.7% quarter-on-quarter (QoQ) due to shorter summers and adverse weather.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Net Profit (PAT):<\/strong> \u20b9128 crore, down 13.51% YoY from \u20b9148 crore last year, and sharply lower by 14.9% QoQ.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>EBITDA:<\/strong>\u00a0\u20b9156 crore, nearly flat YoY (up 0.2%), with EBITDA margin declining to 18.1% from 18.5% in Q1 FY25 (down 39 basis points).<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>EPS:<\/strong>\u00a0\u20b920.10, down from \u20b923.20 in Q1 FY25 and \u20b923.60 in Q4 FY25.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Gross Margin:<\/strong>\u00a055%, down 66 basis points YoY, but up slightly QoQ as input cost pressure began to ease.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Organised Trade Saliency:<\/strong>\u00a0Improved to 30.9% (from 23.3% YoY), driven by e-commerce (14.5%) and modern trade (16.4%). The Naturell (Max Protein) acquisition contributed to growth in nutrition bars\/snacks.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Key Brands and Market Leadership:<\/strong><\/p>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Sugar Free:<\/strong>\u00a096.1% market share in sugar substitutes, category reported MAT growth of 4.9%.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Glucon-D:<\/strong>\u00a0No.1 position at 58.9% market share, category up 2.8% MAT.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Complan:<\/strong>\u00a0Maintains a 4% market share; good performance in the foods segment.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Nycil:<\/strong>\u00a0Leader at 33.3% market share in talcum powders.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Everyuth:<\/strong>\u00a0Market leader in the peel-off and scrub category.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Segment Breakdown:<\/strong>\u00a0Food &amp; Nutrition segment grew 1.6% YoY; Personal Care grew 3.8% YoY.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>PAT Margin:<\/strong>\u00a0At 14.9% (down 271 bps YoY), mainly impacted by non-cash items (deferred tax, amortisation from acquisition).<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Dividend:<\/strong>\u00a0Board recommended final dividend of \u20b96 per equity share of \u20b910, subject to AGM approval.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Stock Split:<\/strong>\u00a0Board approved 1:5 split (\u20b910 face value to \u20b92 each).<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3 id=\"key-management-commentary--strategic-highlights\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Key Management Commentary &amp; Strategic Highlights<\/h3>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Management noted<\/strong> that <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/1491f3ef-9248-4dab-bc9e-ebc45027f64f.pdf\" target=\"_blank\" rel=\"noopener\">performance was subdued<\/a> due to seasonal impacts which included short summers and rains but double-digit growth was seen in non-seasonal brands.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">Focus remains on\u00a0<strong>margin resilience, product innovation, and cost efficiency<\/strong>. Management expects <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/1491f3ef-9248-4dab-bc9e-ebc45027f64f.pdf\" target=\"_blank\" rel=\"noopener\">margin recovery<\/a>, with input costs starting to ease and operational levers becoming effective in upcoming quarters.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">Emphasis on expanding product portfolio, with launches in probiotics (Nutralite), vitamin-fortified foods, and new cheese offerings.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Rural markets continued to outperform urban;<\/strong>\u00a0however, urban demand is recovering with a stable consumption trend.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">International expansion is a strategic priority, aiming for 8\u201310% of revenue from overseas in the next 4\u20135 years.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Long-term outlook:<\/strong>\u00a0Management targets double-digit revenue growth and improved margin profile for FY26, leveraging brand strength, channel expansion, and operational discipline.<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-169992\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7-839x1024.png\" alt=\"Zydus Wellness Q1 FY26 Earnings Results\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"q4-fy25-earnings-snapshot-januarymarch-2025\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Q4 FY25 Earnings Results<\/h2>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Revenue:<\/strong>\u00a0\u20b9913 crore, up 16.7% YoY and 97.7% QoQ, supported by 13% volume growth (especially in small pack sizes). Food &amp; beverages and personal care segments grew by 15.4% and 22.5% YoY, respectively.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Net Profit (PAT):<\/strong>\u00a0\u20b9172 crore, up 14.4% YoY; PAT margin at 18.8%.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>EBITDA:<\/strong>\u00a0\u20b9190 crore, up 17% YoY; EBITDA margin at 20.8%.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Gross Margin:<\/strong>\u00a054.9%.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Product\/Brand Highlights:<\/strong>\u00a0Nycil (33.8% share), Everyuth (leadership in masks and scrubs), Glucon-D (dominance at 58.8%), Sugar-Free (95.9%).<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Dividend:<\/strong>\u00a0\u20b96\/share declared; 1:5 stock split recommended.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Strategic Launches:<\/strong>\u00a0Entry into sheet masks category with three new variants.<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>To view the company&#8217;s previous earnings and latest concall transcripts, <a href=\"https:\/\/44.250.171.167\/symbol\/zyduswell\/\">click here<\/a>\u00a0 to visit the Alphastreet India news channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite. Presenting below are its Q1 FY26 earnings results. &nbsp; Q1 FY26 Earnings Results Consolidated [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":169992,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,6351],"tags":[11440,14340],"class_list":["post-169988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-consumer-stocks","tag-sugarfree","tag-wellness-products"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/1-7.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":170087,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-q1-fy26-earnings-results\/","url_meta":{"origin":169988,"position":0},"title":"Zydus Lifesciences Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 12, 2025","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Zydus Lifesciences Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":146495,"url":"https:\/\/alphastreet.com\/india\/zydus-wellness-ltd-q4fy23-results-out-revenue-grows-by-11\/","url_meta":{"origin":169988,"position":1},"title":"Zydus Wellness Ltd Q4FY23 results out, revenue grows by 11%","author":"Chirag Gupta","date":"May 17, 2023","format":false,"excerpt":"Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite. Zydus Wellness Ltd reported Total revenue for Q4 FY23\u2026","rel":"","context":"In &quot;Consumer&quot;","block_context":{"text":"Consumer","link":"https:\/\/alphastreet.com\/india\/category\/consumer-stocks\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":172227,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-q2-fy26-earnings-results\/","url_meta":{"origin":169988,"position":2},"title":"Zydus LifeSciences Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"November 7, 2025","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Zydus LifeSciences Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169732,"url":"https:\/\/alphastreet.com\/india\/marico-ltd-q1-fy26-earnings-results-8-rise-in-profits\/","url_meta":{"origin":169988,"position":3},"title":"Marico Ltd Q1 FY26 Earnings Results &#8211; 8% rise in Profits","author":"Chirag Gupta","date":"August 4, 2025","format":false,"excerpt":"Marico Limited is one of India's leading consumer goods companies operating in global beauty and wellness categories. It is present in over 25 countries across emerging markets of Asia and Africa. It nurtures leading brands across categories of hair care, skin care, edible oils, healthy foods, male grooming and fabric\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Marico Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/6-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/6-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/6-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/6-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/6-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/6-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169685,"url":"https:\/\/alphastreet.com\/india\/dabur-india-ltd-q1-fy26-earnings-results-revenue-up-1-7-net-profit-rises-nearly-3-yoy\/","url_meta":{"origin":169988,"position":4},"title":"Dabur India Ltd Q1 FY26 Earnings Results \u2013 Revenue Up 1.7%, Net Profit Rises Nearly 3% YoY","author":"Divyansh_Kasana","date":"August 1, 2025","format":false,"excerpt":"Dabur India Limited is one of India\u2019s leading FMCG companies specializing in Ayurvedic and natural healthcare products. With a strong heritage and expansive distribution network across India and global markets, Dabur continues to focus on innovation, quality, and consumer trust in its diverse product portfolio. Q1 FY26 Earnings Summary (Apr\u2013Jun\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DABUR.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DABUR.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DABUR.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DABUR.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DABUR.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DABUR.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":140936,"url":"https:\/\/alphastreet.com\/india\/zydus-lifescience-net-profit-soars-by-23-in-q3fy23\/","url_meta":{"origin":169988,"position":5},"title":"Zydus lifescience net profit soars by 23% in Q3FY23","author":"Chirag Gupta","date":"February 10, 2023","format":false,"excerpt":"Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended December 31, 2022. The company had posted a consolidated net profit of INR 511 crore in the same period last fiscal, Zydus Lifesciences Ltd said in a regulatory\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=169988"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169988\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/169992"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=169988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=169988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=169988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}